|

Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

RECRUITINGPhase 2Sponsored by University of Maryland, Baltimore
Actively Recruiting
PhasePhase 2
SponsorUniversity of Maryland, Baltimore
Started2020-12-01
Est. completion2025-12-31
Eligibility
Age40 Years – 80 Years
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04698564

Summary

This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population

Eligibility

Age: 40 Years – 80 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

1. Age greater than 40 and less than 80 years
2. Clinical suspicion or history of prostate cancer reflected by one of the following:

   * PSA \> 4ng/ml
   * Abnormal DRE exam
   * Known tissue diagnosis of prostate cancer from prior workup
3. Patient planning to undergo either a MRI targeted biopsy or radical prostatectomy for prostate cancer workup or treatment

Exclusion Criteria:

1. Inability to undergo MRI scan
2. Inability to receive IV contrast as per institutional protocol.

Conditions2

CancerProstate Cancer

Locations1 site

University of Maryland Medical Center
Baltimore, Maryland, 21201
Mohummad Siddiqui, MD

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.